Relative Bioavailability of Silybin A and Silybin B From 2 Multiconstituent Dietary Supplement Formulations Containing Milk Thistle Extract: A Single-dose Study.

What Was Tested

The paper reports a study of Copper (Supplement), published as a randomized controlled trial.

The purpose of this study was to compare the bioavailability between 2 milk thistle-containing dietary supplements, Product B and IsaGenesis, in healthy volunteers.

Who Took Part

According to the abstract, 12 volunteers were involved.

PubMed indexes the participants as young adults and adults, both men and women.

How the Study Was Run

In design terms this was a randomized, open-label and crossover study.

Because people in this Copper (Supplement) study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

Everyone knew when Copper (Supplement) was being given (open label), which is simpler to run but leaves more room for expectations to affect what is reported.

Each person switched between Copper (Supplement) and the comparison at some point, usually with a gap in between.

Serial blood samples were obtained at 0, 0.5, 1, 1.5, 2, 3, 4, 6, and 8 hours and analyzed via LC-MS/MS.

What Was Measured

The subject headings attached to it are Antioxidants, Area Under Curve, Biological Availability, Capsules, Chromatography, Liquid, Dietary Supplements and Drug Compounding.

The authors tagged it with the keywords absorption, formulation, milk thistle and silybin.

What This Means in Plain Language

The paper is a randomized, open-label and crossover study of Copper (Supplement) in 12 volunteers.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2018 (Clinical therapeutics), a journal based in United States.

More context: the Copper (Supplement) compound page, all human trials.